New study tests simpler procedure for stomach precancer

NCT ID NCT07161479

Recruiting now Disease control Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two endoscopic procedures—argon plasma coagulation (APC) and endoscopic mucosal resection (EMR)—for treating small (1 cm or smaller) precancerous growths in the stomach called gastric adenomas with low-grade dysplasia. About 160 adults will be randomly assigned to receive either APC or EMR. The main goal is to see if APC is as effective as EMR at preventing the growth from coming back, while possibly being safer and faster.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Argon plasma coagulation (APC) and endoscopic mucosal resection (EMR) are both procedures used to remove precancerous growths in the stomach.
What this could lead to: If APC works as well as EMR, it could offer a simpler, safer, and cheaper option for treating small precancerous stomach growths.
What could go wrong: This is a relatively small trial (160 people) and results may not apply to larger or more advanced growths. APC does not provide a tissue sample, so there is a risk of incomplete removal or recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSPLASIA STOMACH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric adenoma gastric neoplasm precancerous condition

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DYSPLASIA STOMACH GASTRIC ADENOMA PRECANCEROUS CONDITIONS STOMACH NEOPLASMS

Contacts and locations

Locations

Kangbuk Samsung hospital
RECRUITING

Seoul, 03181, South Korea
National Cancer Center
RECRUITING

Goyang-si, 10408, South Korea
Samsung Medical Center
RECRUITING

Seoul, 06351, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.